In the context of PD, ATP10B has recently been recognized as a potential genetic risk factor, with loss-of-function mutations found in a subset of PD patients and decreased expression of ATP10B mRNA found in idiopathic PD [16]. This evidence concerns the gene ATP10B and Parkinson disease.